Colombia’s Constitutional Court has ordered health insurers to conduct interdisciplinary evaluations of both physical and mental health before denying requests for reconstructive surgery, a ruling that immediately reshapes how the country’s strained system handles such claims. The decision, issued in response to a case involving a woman who developed chronic pain and depression from excess skin after bariatric surgery, found that a review committee composed solely of plastic surgeons had failed to consider her psychological diagnoses. The court declared that the right to health encompasses recovery and improvement of a person’s condition, and that reconstructive procedures cannot be dismissed as merely cosmetic when they address functional and emotional harm. Insurer Sanitas must now convene a panel including psychiatry, psychology, nutrition, and other specialties to reassess the patient’s case, setting a precedent for all EPS entities across the country.

This judicial intervention arrives as Colombia’s health superintendent separately ordered the four largest insurers—Nueva EPS, Sanitas, Sura, and Salud Total, which together cover some 28 million people—to implement immediate action plans to reduce appointment backlogs. The regulator acted after a surge in user complaints in July, citing delays in obtaining consultations and a pattern of patients resorting to formal grievances to access care. The twin pressures from courts and regulators reflect a system in which financial strain and administrative hurdles routinely obstruct timely treatment, even as demand for both medically necessary and elective procedures grows.

Viewed from Canada’s Atlantic coast, the Colombian developments echo a familiar frustration. In Corner Brook, Newfoundland, a 26-year-old mother has seen her breast reduction surgery, intended to alleviate chronic back pain and spinal curvature, rescheduled four times since 2024 and now pushed to August 2028. The repeated postponements have deepened her physical discomfort and contributed to depression, illustrating how public systems can leave patients in limbo for years. In Central Asia, the consequences of unmet demand and weak oversight are more acute: a social-media-driven boom in cosmetic surgery across Kazakhstan, Kyrgyzstan, and Uzbekistan has produced a rising toll of botched procedures and deaths, including a Kazakh influencer who died after liposuction in May. Authorities in Kyrgyzstan acknowledge that over 1,300 companies are illegally performing medical or pharmaceutical activities, yet enforcement remains patchy and some sanctioned practitioners continue to operate.

Italian health authorities in Lombardy offer a contrasting picture, reporting a 10-percentage-point improvement in timely delivery of priority outpatient services in Milan and progress toward a unified regional booking system expected to be fully operational by end-2026. While these gains suggest that targeted management can ease backlogs, the global pattern underscores a deeper tension: as surgical interventions become more central to both physical and psychological well-being, health systems from Bogotá to Bishkek are struggling to balance demand, safety, and equitable access. The next milestone in Colombia will be the Superintendency’s verification of whether the four EPS meet their appointment-reduction targets, while the Constitutional Court’s ruling will be tested as interdisciplinary committees begin reviewing pending reconstructive surgery requests.